NIH #R01CA281759
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial
Active
- Amount
- $600K–$700K
- Period
- 2023-09-01 → 2028-08-31
- PIs
- 2
Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH